13B. Experience With the “Banerji Protocols“ in Treatment of Chronic Disease

Focus Areas: Integrative Approaches to Care

Specific effects of homeopathic treatment are often dismissed as unbelievable due to use of remedies diluted beyond Avogadro’s number. Recent basic science research suggests that this argument will no longer hold water with the demonstration that classically prepared ultradilute homeopathic medicines (HM) contain measurable source nanoparticles (NP) and/or silica NP with adsorbed source materials that are heterogeneously dispersed in colloidal solution and have biological properties that differ substantially from bulk forms of the same substance. These findings will soon address the plausibility question; however, individualized homeopathy may remain obscure due to the need for hundreds of hours of training required for effective practice where a different remedy may be needed for every patient regardless of condition. The Banerji Protocols help to alleviate this obstacle.

The Prasanta Banerji Homeopathic Research Foundation (http://pbhrfindia.org) is well known for its cancer treatment protocols, having been identified by NCI in 1999 for its Best Case Series with subsequent translational research on specific homeopathic medicines (HM) being done at MD Anderson. Less known are the Protocols for numerous serious conditions that have been developed over four generations of homeopathic practice with thousands of patients in Kolkata, India. The new book from Drs Prasanta and Pratip Banerji, published in June 2013, contains dozens of protocols for the treatment of conditions such as chronic renal failure, dysfunctional uterine bleeding, hepatitis, inflammatory bowel disease, and traumatic brain injury. Dr Barbara Sarter has spent many months collecting data in the Kolkata clinic. She and Dr Joyce Frye have already used many of these protocols in their respective US homeopathic practices with excellent results. The Protocols suggest highly efficacious and cost-effective treatments of numerous conditions for which conventional medicine has limited options.